{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:21:37Z","timestamp":1793917297929,"version":"4.8.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270551"],"award-info":[{"award-number":["82270551"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024SF-YBXM-141"],"award-info":[{"award-number":["2024SF-YBXM-141"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2022ZDLSF03\\u201303"],"award-info":[{"award-number":["2022ZDLSF03\\u201303"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2022ZDLSF03\\u201303and 2024SF-YBXM-141"],"award-info":[{"award-number":["2022ZDLSF03\\u201303and 2024SF-YBXM-141"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clinre.2025.102635","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T11:12:22Z","timestamp":1749294742000},"page":"102635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Glucocorticoids accelerate the reduction of disease severity and biochemical parameters in drug-induced liver injury: Assess the causal relationship using the updated RUCAM scale"],"prefix":"10.1016","volume":"49","author":[{"given":"Punan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanya","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinre.2025.102635_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.clinre.2025.102635_bib0002","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinre.2025.102635_bib0003","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.clinre.2025.102635_bib0004","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/liv.15262","article-title":"Incidence and risk factors of drug-induced liver injury","volume":"42","author":"Li","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2025.102635_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2015.12.017","article-title":"Adverse drug reactions and organ damage: the liver","volume":"28","author":"Licata","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clinre.2025.102635_bib0006","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejim.2021.10.035","article-title":"Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management","volume":"97","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.clinre.2025.102635_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2019.08.002","article-title":"Epidemiology, predisposing factors, and outcomes of drug-induced liver injury","volume":"24","author":"Bj\u00f6rnsson","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.clinre.2025.102635_bib0008","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1053\/j.gastro.2016.10.010","article-title":"Drug induced liver injury in patients with preexisting chronic liver disease in drug development\u2013 how to identify and manage?","volume":"151","author":"Naga Chalasani","year":"2016","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clinre.2025.102635_bib0009","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0025-7125(16)32221-0","article-title":"Treatment of liver disease with corticosteroids","volume":"57","author":"Lesesne","year":"1973","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.1016\/j.clinre.2025.102635_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102635_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11010015","article-title":"Treatment of drug-induced liver injury","volume":"11","author":"Teschke","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinre.2025.102635_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.820724","article-title":"Role of corticosteroids in drug-induced liver injury. a systematic review","volume":"13","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.clinre.2025.102635_bib0013","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.cgh.2022.12.040","article-title":"The evolving profile of idiosyncratic drug-induced liver injury","volume":"21","author":"Fontana","year":"2023","journal-title":"Clinical Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.clinre.2025.102635_bib0014","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1751-2980.12383","article-title":"Beneficial effect of corticosteroids for patients with severe drug-induced liver injury","volume":"17","author":"Hu","year":"2016","journal-title":"J Dig Dis"},{"issue":"1","key":"10.1016\/j.clinre.2025.102635_bib0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000322298","article-title":"Steroid and ursodesoxycholic acid combination therapy in severe drug-induced liver injury","volume":"84","author":"Wree","year":"2011","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.clinre.2025.102635_bib0016","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/liv.13538","article-title":"N-acetylcysteine and prednisolone treatment improved serum biochemistries in suspected flupirtine cases of severe idiosyncratic liver injury","volume":"38","author":"Borlak","year":"2017","journal-title":"Liver Int"},{"issue":"26","key":"10.1016\/j.clinre.2025.102635_bib0017","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015886","article-title":"Prednisone is not beneficial for the treatment of severe drug-induced liver injury","volume":"98","author":"Wan","year":"2019","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.clinre.2025.102635_bib0018","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.26678","article-title":"Steroid use in acute liver failure","volume":"59","author":"Karkhanis","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.clinre.2025.102635_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12113751","article-title":"Histological characteristics and management of hepatitis on immune checkpoint inhibitors: a retrospective descriptive study","volume":"12","author":"Parlati","year":"2023","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.clinre.2025.102635_bib0020","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.14309\/ajg.0000000000002340","article-title":"Acute liver failure guidelines","volume":"118","author":"Shingina","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102635_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010014","article-title":"RUCAM in drug and herb induced liver injury: the update","volume":"17","author":"Danan","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinre.2025.102635_bib0022","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-023-10633-7","article-title":"Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update","author":"Mao","year":"2024","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.clinre.2025.102635_bib0023","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin. Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.clinre.2025.102635_bib0024","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jhep.2023.04.033","article-title":"Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report","volume":"79","author":"Andrade","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102635_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/livers5010008","article-title":"Immunology highlights of four major idiosyncratic DILI subtypes verified by the RUCAM: a new evidence-based classification","volume":"5","author":"Teschke","year":"2025","journal-title":"Livers"},{"issue":"1","key":"10.1016\/j.clinre.2025.102635_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.clinre.2025.102635_bib0027","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/hep4.1959","article-title":"Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports","volume":"6","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.clinre.2025.102635_bib0028","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis\u2020","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clinre.2025.102635_bib0029","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","author":"Andrade","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102635_bib0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clinre.2017.08.003","article-title":"Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury","volume":"42","author":"Pang","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"8","key":"10.1016\/j.clinre.2025.102635_bib0031","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/apt.17373","article-title":"Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: an international, multicentre, propensity score-matched analysis","volume":"57","author":"Niu","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"11\u201312","key":"10.1016\/j.clinre.2025.102635_bib0032","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/apt.17246","article-title":"Review article: clinical assessment of suspected drug-induced liver injury and its management","volume":"56","author":"Vuppalanchi","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.clinre.2025.102635_bib0033","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2022.09.010","article-title":"Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury","volume":"78","author":"Chalasani","year":"2023","journal-title":"J Hepatol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:25:03Z","timestamp":1778840703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740125001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2210740125001123"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102635","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoids accelerate the reduction of disease severity and biochemical parameters in drug-induced liver injury: Assess the causal relationship using the updated RUCAM scale","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102635"}}